Zhejiang Provincial Key Laboratory for Technology and Application of Model Organisms, Key Laboratory of Laboratory Medicine, Ministry of Education, China, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Nelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, New York, USA.
Mol Cell Biol. 2018 Oct 15;38(21). doi: 10.1128/MCB.00273-18. Print 2018 Nov 1.
Bladder cancer (BC) ranks as the sixth most common cancer in the United States and is the leading cause of death in patients with urinary malignancies. p63 is a member of the p53 family and is believed to function as a tumor suppressor in human BCs. Our most recent studies revealed a previously unknown function of the RING of XIAP in promoting microRNA 4295 (miR-4295) transcription, thereby reducing p63α protein translation and enhancing normal urothelial transformation, whereas p63α upregulates hsp70 transcription, subsequently activating the HSP70/Wasf3/Wave3/matrix metalloproteinase 9 (MMP-9) axis and promoting BC cell invasion via initiating the transcription factor E2F1. In this study, we found that p63α inhibited cyclin D1 protein expression, subsequently decreasing the ability of BC cell anchorage-independent growth and tumorigenicity Mechanistic studies demonstrated that p63α expression is able to downregulate cyclin D1 gene transcription through attenuation of c-Myc mRNA stability. We further show that the reduction of miR-141-3p expression by p63α directly releases its inhibition of 3' untranslated region (UTR) activity of AU-rich element RNA-binding factor 1 (AUF1) mRNA, thereby increasing AUF1 protein translation and further resulting in degradation of c-Myc mRNA, which, in turn, reduces cyclin D1 gene transcription and BC cell anchorage-independent growth. Collectively, our results demonstrate that p63α is a negative regulator of BC cell tumorigenic growth, a distinctly different function than its promotion of BC invasion, thus providing further new insight into the "two faces" of p63α in regulation of BC cell tumorigenic growth and progression/invasion.
膀胱癌(BC)在美国排名第六,是泌尿系统恶性肿瘤患者死亡的主要原因。p63 是 p53 家族的成员,被认为在人类 BC 中起肿瘤抑制作用。我们最近的研究揭示了 XIAP 的 RING 域促进 microRNA 4295(miR-4295)转录的未知功能,从而减少 p63α 蛋白的翻译并增强正常尿路上皮转化,而 p63α 上调 hsp70 转录,随后激活 HSP70/Wasf3/Wave3/基质金属蛋白酶 9(MMP-9)轴,通过启动转录因子 E2F1 促进 BC 细胞侵袭。在这项研究中,我们发现 p63α 抑制细胞周期蛋白 D1 蛋白的表达,从而降低 BC 细胞锚定非依赖性生长和致瘤性的能力。机制研究表明,p63α 通过衰减 c-Myc mRNA 稳定性,能够下调细胞周期蛋白 D1 基因的转录。我们进一步表明,p63α 对 miR-141-3p 的表达减少直接释放其对 AU 丰富元件 RNA 结合因子 1(AUF1)mRNA 3'非翻译区(UTR)活性的抑制作用,从而增加 AUF1 蛋白的翻译,进而导致 c-Myc mRNA 的降解,从而降低细胞周期蛋白 D1 基因的转录和 BC 细胞锚定非依赖性生长。总的来说,我们的研究结果表明 p63α 是 BC 细胞致瘤性生长的负调节剂,与促进 BC 侵袭的功能明显不同,从而为 p63α 在调节 BC 细胞致瘤性生长和进展/侵袭中的“两面性”提供了新的见解。